Investor Perspective: How Can Partnering with Pharma Impact Startup Success?

Van derden

01/07/21

Do you want to make it big in biotech? Interactions with companies that have already made it big, may be a key success factor. There are many ways in which biotech start-ups can interact with pharma companies. Pharma might be a parent company for a spinout. They may be an early- or late-stage investor, or an acquisition partner. Alternatively or additionally, they may be a development partner with extensive knowledge and a network to tap into.

 

During this virtual event a panel of investors shares their views on collaborating and partnering with pharma companies. What do entrepreneurs need to consider in their partnering strategy? Which type of partnering fits at which stage? What are the opportunities and pitfalls? Join the Johnson & Johnson Innovation webinar as we explore potential success factors for biotech startups.

 

You are most welcome to join us on 1 July. Please register through: https://partneringwithpharma.splashthat.com/partner